We analyzed blood plasma concentrations of matrix metalloproteinase-1 and -3 (MMP-1; MMP-3), the tissue inhibitor of metalloproteinase-1 (TIMP-1) and the complex MMP-1/ TIMP-1, and looked for any correlation with prostate cancer stage. These components were measured by ELISA tests specific for these
Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer
β Scribed by Takaki Yoshikawa; Haruhiko Cho; Akira Tsuburaya; Osamu Kobayashi
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 217 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1436-3291
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Tissue inhibitor of metalloproteinaseβ1 (TIMPβ1) has paradoxical multifunctional roles in tumorigenesis: inhibition of the catalytic activity of matrix metalloproteinases and apoptosis as well as promotion of angiogenesis and tumor growth. Elevated TIMPβ1 levels have bee
Previously, the authors clarified that the plasma concentration of tissue inhibitor of matrix metalloproteinase 1 (TIMP-1) in patients with gastric carcinoma was a significant predictor of tumor invasiveness and metastasis. ## METHODS. To further clarify the clinical significance of TIMP-1, the a
## Abstract ## BACKGROUND. Tissue inhibitors of metalloproteinase (TIMPs) have at least 2 different functions. They inhibit the catalytic activity of matrix metalloproteinases, and they act as growth factors. ## METHODS. Pretreatment ethylenediamine tetracetic acid plasma TIMPβ1 was assayed from